BASEMENT-MEMBRANES IN CERVICAL-CANCER - RELATIONSHIP TO PELVIC LYMPH-NODE METASTASIS AND PROGNOSIS

被引:7
|
作者
BREMER, GL
TIEBOSCH, ATMG
VANDERPUTTEN, HWHM
DEHAAN, J
ARENDS, JW
机构
[1] UNIV LIMBURG,DEPT PATHOL,6200 MD MAASTRICHT,NETHERLANDS
[2] UNIV LIMBURG HOSP,6200 MD MAASTRICHT,NETHERLANDS
关键词
D O I
10.1006/gyno.1995.1154
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this retrospective study, the pattern of basement membrane expressed by type IV collagen immunostaining was evaluated in 156 patients with cervical cancer FIGO stage IB-IV. Staining patterns were assessed semiquantitatively and divided into three patterns, according to intensity and continuity of staining: thick basement membranes with minimal discontinuity (pattern I), thin basement membranes with moderate discontinuity (pattern II), and fragmentary or absent basement membranes (pattern III). Correlations between basement membrane pattern, FIGO stage, and pelvic lymph node status were tested using chi(2) statistics. Kaplan-Meier estimates of disease-free survival were calculated for groups of patients with basement membrane pattern I, II, or III and compared using the log-rank test. A fragmented or absent basement membrane, pattern III, was more frequently observed in advanced cervical cancer stage IIB/IV (P = 0.02). In patients with early cervical cancer stage Ib/IIA this pattern was associated with the presence of pelvic lymph node metastasis (P < 0.0001) and significantly associated with a decreased survival rate (P = 0.05). In advanced-stage disease no prognostic value was observed. These data indicate that in patients with early-stage cervical cancer the basement membrane pattern, expressed as the type IV collagen staining pattern, may be a useful marker in predicting lymph node metastasis and survival. (C) 1995 Academic Press, Inc.
引用
收藏
页码:351 / 355
页数:5
相关论文
共 50 条
  • [21] BIOCHEMICAL MARKERS AS A PREDICTOR FOR LYMPH-NODE INVOLVEMENT IN PATIENTS WITH CERVICAL-CANCER OF THE UTERUS
    KOBAYASHI, H
    FUJISHIRO, S
    TERAO, T
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1994, 4 (05) : 1053 - 1059
  • [22] SCALENE LYMPH-NODE BIOPSY IN THE PREOPERATIVE EVALUATION OF PATIENTS WITH RECURRENT CERVICAL-CANCER
    MANETTA, A
    PODCZASKI, ES
    LARSON, JE
    DEGEEST, K
    MORTEL, R
    GYNECOLOGIC ONCOLOGY, 1989, 33 (03) : 332 - 334
  • [23] LYMPHOTOXIN PRODUCTION BY REGIONAL LYMPH-NODE LYMPHOCYTES IN PATIENTS WITH UTERINE CERVICAL-CANCER
    MATSUNAGA, K
    MASHIBA, H
    KURANO, A
    JIMI, S
    JOURNAL OF CLINICAL IMMUNOLOGY, 1990, 10 (05) : 265 - 272
  • [24] Prognosis and recurrence pattern of patients with cervical carcinoma and pelvic lymph node metastasis
    Shrestha, E.
    Shrestha, D. R.
    EJC SUPPLEMENTS, 2008, 6 (09): : 159 - 159
  • [25] PROGNOSIS AND RECURRENCE PATTERN OF PATIENTS WITH CERVICAL CARCINOMA AND PELVIC LYMPH NODE METASTASIS
    Shrestha, E.
    Hong, L. J.
    Ying, X.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 543 - 543
  • [26] Prognosis and recurrence pattern of patients with cervical carcinoma and pelvic lymph node metastasis
    Shrestha, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [27] Loss of basement membrane heparan sulfate expression is associated with pelvic lymph node metastasis in invasive cervical cancer
    Kodama, J
    Shinyo, Y
    Hasengaowa
    Kusumoto, T
    Seki, N
    Nakamura, K
    Hongo, A
    Hiramatsu, Y
    ONCOLOGY REPORTS, 2005, 14 (01) : 89 - 92
  • [28] CT OF CERVICAL LYMPH-NODE CANCER
    MANCUSO, AA
    MACERI, D
    RICE, D
    HANAFEE, W
    AMERICAN JOURNAL OF ROENTGENOLOGY, 1981, 136 (02) : 381 - 385
  • [29] CIS-DIAMMINEDICHLOROPLATINUM-II BASED COMBINATION CHEMOTHERAPY FOR THE CONTROL OF EXTENSIVE PARAAORTIC LYMPH-NODE METASTASIS IN CERVICAL-CANCER
    PIVER, MS
    LELE, SB
    MALFETANO, JH
    GYNECOLOGIC ONCOLOGY, 1987, 26 (01) : 71 - 76
  • [30] HISTOLOGIC DIFFERENTIATION, CANCER VOLUME, AND PELVIC LYMPH-NODE METASTASIS IN ADENOCARCINOMA OF THE PROSTATE
    MCNEAL, JE
    VILLERS, AA
    REDWINE, EA
    FREIHA, FS
    STAMEY, TA
    CANCER, 1990, 66 (06) : 1225 - 1233